Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Statements of Operations

v3.26.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 1,026 $ 768 $ 1,470
Costs of revenues 1,828 1,553 1,508
Gross loss (802) (785) (38)
Operating expenses:      
Research and development, net 34,820 35,091 34,082
Sales and marketing 5,039 5,430 5,194
General and administrative 7,544 8,347 7,571
Total operating expenses 47,403 48,868 46,847
Operating loss (48,205) (49,653) (46,885)
Financial income, net 1,784 336 3,385
Net loss $ (46,421) $ (49,317) $ (43,500)
Basic net loss per ordinary share (in Dollars per share) $ (0.42) $ (0.61) $ (0.6)
Weighted-average number of ordinary shares used in computing basic net loss per ordinary share (in Shares) 111,382,369 80,949,032 72,021,520
Diluted net loss per ordinary share (in Dollars per share) $ (0.42) $ (0.61) $ (0.61)
Weighted-average number of ordinary shares used in computing diluted net loss per ordinary share (in Shares) 111,382,369 80,949,032 72,053,372